1,040
Participants
Start Date
May 14, 2019
Primary Completion Date
November 8, 2023
Study Completion Date
November 8, 2023
Edoxaban Monotherapy
Taking edoxaban (Lixiana™, Daiichi-Sankyo Inc.) 60mg once daily. The dose of edoxaban will be reduced to 30mg once daily in patients with estimated creatinine clearance 15≤CrCL≤50mL/min by Cockcroft-Gault equation or weight is ≤60kg.
Edoxaban plus Single Antiplatelet Agent
Type of antiplatelet agent is dependant upon the investigator's discretion, but aspirin 100mg once daily or clopidogrel 75mg once daily was recommended.
Hallym University Medical Center, Anyang
Soon Chun Hyang University Hospital Bucheon, Bucheon-si
Keimyung University Dongsan Medical Center, Daegu
Dongguk University Ilsan Hospital, Ilsan
Dong-A University Hospital, Pusan
Inje University Haeundae Paik Hospital, Pusan
Seoul National University Bundang Hospital, Seongnam
Asan Medical Center, Seoul
Kangdong KyungHee University hospital, Seoul
Konkuk University Medical Center, Seoul
Samsung Medical Center, Seoul
Seoul National University Hospital, Seoul
The Catholic Univ. of Korea, Seoul St. Mary's Hospital, Seoul
The Catholic Univ.of Korea Eunpyeong St.Mary's Hospital, Seoul
VHS medical center, Seoul
The Catholic University of Korea, St. Vincent's Hospital, Suwon
Ulsan Univeristy Hospital, Ulsan
Pusan National University Yangsan Hospital, Yangsan
CardioVascular Research Foundation, Korea
OTHER
Gi-Byoung Nam
OTHER